Pharmaceutical compositions including low dosages of desmopressin

CAFC
  • US 7,579,321 B2
  • Filed: 07/15/2008
  • Issued: 08/25/2009
  • Est. Priority Date: 05/07/2002
  • Status: Active Grant
First Claim
Patent Images

1. A method for inducing voiding postponement in a patient while reducing the risk that the patient develops hyponatremia comprising delivering to the bloodstream of the patient an amount of desmopressin no more than about 2 ng/kg by intranasal, transdermal, intradermal, transmucosal, or conjunctival administration, said amount being therapeutically effective to produce an antidiuretic effect lasting for no more than between about 4 and about 6 hours.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×